OncologySTAT: Would you give an update on treatment of early-stage diffuse large B-cell lymphoma (DLBCL)? Would you discuss the data surrounding the optimal number of cycles of rituximab (R) plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) and the need for consolidation with radiation therapy? What’s the optimal treatment for bulky vs nonbulky disease? Dr. Goy: Traditionally, combined modality therapy (ie, chemotherapy + radiation) has been the standard in early-stage diffuse...